UncategorizedVectorY’s new ALS therapy moves forward after FDA clearance Empower Meds / December 3, 2025
UncategorizedJunevity lands more funding for siRNA-powered cellular reprogramming Empower Meds / December 3, 2025
UncategorizedFunction hires Ziad Sultan from Spotify to lead AI and product development – Longevity.Technology Empower Meds / December 3, 2025
UncategorizedFountain Life claims $20M annual ROI from executive‑health program – Longevity.Technology Empower Meds / December 3, 2025
UncategorizedGenSight Biologics gets green light for GS010/LUMEVOQ dose‑ranging study in France – Longevity.Technology Empower Meds / December 3, 2025
UncategorizedProMIS Neurosciences supports plasma pTau as early Alzheimer’s endpoint – Longevity.Technology Empower Meds / December 3, 2025
UncategorizedAltPep’s peptide SOBIN-AD shows positive preclinical Alzheimer’s results – Longevity.Technology Empower Meds / December 3, 2025
UncategorizedNew studies tie social support to longevity of older adults Empower Meds / December 2, 2025
